Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

LXRX Lexicon Pharmaceuticals Inc

0,642

-0,0816 (-11,28%)

21 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Lexicon Pharmaceuticals Charts.

Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Lexicon Pharmaceuticals Charts.

News Lexicon Pharmaceuticals Inc

Lexicon Announces Receipt of Complete Response Letter for Zynquista™ (sotagliflozin)
Freitag 20 Dezember 2024 (2 Tage vor) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Dienstag 17 Dezember 2024 (5 Tage vor) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Dienstag 10 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 2 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Lexicon Announces Completion of Enrollment in Phase 2B PROGRESS Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)
Dienstag 26 November 2024 (4 Wochen vor) • GlobeNewswire Inc.

Lexicon Pharmaceuticals to Participate in December Investor Conferences
Montag 25 November 2024 (4 Wochen vor) • GlobeNewswire Inc.

Lexicon to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA
Freitag 22 November 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 20 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Lexicon Appoints Ivan H. Cheung to Board of Directors
Mittwoch 20 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Post-Hoc Analysis Demonstrating Sotagliflozin Benefits Across Broad Spectrum of Heart Failure Patient Populations is Among Four Lexicon-Supported Presentations at the American Heart Association’s (AHA) Sessions 2024 in Chicago
Donnerstag 14 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 12 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Weitere Lexicon Pharmaceuticals Inc News-Artikel

JP Morgan Chase

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen